Gilead signals beyond the news: 40+ signals from 6 sources
The latest Gilead signal on this page is from Sep 29, 2026 (Patents): "Gilead Sciences, Inc.'s patent output is slowing: 37 grants in the past year, 2 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (9) and Employee growth (7).
Public (GILD)Biotechnology Research10,000+ employeesgilead.comLinkedIn
- Signals
- 40+
- Sources
- 6
- Last 90 days
- 27
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Gilead signals by source
40+ signals for Gilead across 6 sources.
Patents · Patent pace
Gilead Sciences, Inc.'s patent output is slowing: 37 grants in the past year, 2 in the past 30 days.
Over the past year Gilead Sciences, Inc. received 37 US patent grants; the recent pace (4 in 90 days) is slowing versus its trailing baseline.
- Grants, 12 months
- 37
- Grants, 90 days
- 4
- Grants, 30 days
- 2
- Pace
- Decelerating
Reddit · Customer feedback
A Goldman Sachs analyst report highlighted that Gilead's Hepatitis C cure is projected to generate less than $4 billion in annual revenue, down from a cumulative total of $73 billion, questioning...
Post: "“Is curing patients a sustainable business model?” Goldman Sachs analysts ask. Analyst report notes that Gilead’s hep C cure will make less than $4 billion..."
- Subreddit
- r/biotech
- Upvotes
- 300
- Comments
- 59
- Sentiment
- Neutral
Glassdoor · Growth opportunities
Employees report limited mentorship and unclear career paths
Interns mention limited mentorship and projects stalling, while one reviewer notes that career growth and recognition is not based on merit.
- Overall rating
- 3.6 of 5
- CEO approval
- 74%
- Reviews read
- 10
- Review window
- Aug 19, 2026 to Sep 9, 2026
Glassdoor · Poor work life balance
Employees report high workload and poor work life balance
One reviewer notes a very poor work life balance with high workload, while another mentions high work volume as a key con.
- Overall rating
- 3.6 of 5
- CEO approval
- 74%
- Reviews read
- 10
- Review window
- Aug 19, 2026 to Sep 9, 2026
Patents · Patent counsel
Gilead Sciences, Inc. uses Greenberg Traurig LLP as outside IP counsel.
Greenberg Traurig LLP is the attorney of record on Gilead Sciences, Inc.'s recent US patent work, including a grant in 2026-09.
- Law firm
- Greenberg Traurig LLP
- Law firm domain
- gtlaw.com
- Matter date
- Sep 8, 2026
Website changes · Community engagement
Gilead added a prominent collaboration with National Geographic CreativeWorks to highlight its global-health and access mission.
Added text: “BRIDGE TO BREAKTHROUGH Gilead has collaborated with National Geographic CreativeWorks to tell the story of how scientific innovation leads to real-world impact,” with a link to “Global Health and Access.”
- Page
- /
Website changes · Partnership announcement
Gilead added a dedicated employment-verification process for U.S. employees, directing users to Experian Verify or contacting customer service support.
Added text: “Employment Verification To request a verification of employment for U.S. Gilead employees, visit www.experianverify.com or contact Experian Verify customer service support at 404-382-5400.”
- Page
- /contact-us
Podcasts · Tech adoption
AUTM on the Air discusses Gilead: tech adoption
"In the case of Gilead, actually Remdesivir, or the treatment of COVID-19, is one of the medications that use the Captisol technology."
- Podcast
- AUTM on the Air
- Episode
- Advancing Biopharma Innovation with Ruben Flores-Saaib
- Speaker
- Ruben Flores-Saaib
- Speaker role
- Counterparty
Podcasts · Sponsorship
Gilead Sciences sponsors The Readout Loud
What sets us apart is our unique and complementary strength across two transformative platforms, Gillian's leadership in antibody drug conjugates, or ADCs, and Kite's pioneering work in CAR-T cell therapies.
- Podcast
- The Readout Loud
- Episode
- 407: The mysterious case of Eli Lilly's obesity drug
Employee growth · Headcount change
Slow growth (0% YoY) for a enterprise company with 14,493 employees.
Company's 0% headcount growth represents slow expansion for a enterprise company. This adds approximately 0 employees lost over the past year.
- Total headcount
- 14,493
- Company growth, 1 year
- 0%
- Median tenure
- 5 years
Showing 10 of 40+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Gilead with the Signal API
One POST /v1/companies/enrich call with gilead.com returns Gilead signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "gilead.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Gilead other signals
What signals does Autobound track for Gilead besides news and filings?
What are people saying about Gilead online?
What do employees say about working at Gilead?
Has Gilead been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .